| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 1468 | 2018 |
| Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ... The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016 | 1113 | 2016 |
| Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression MW Nachtigal, Y Hirokawa, DL Enyeart-VanHouten, JN Flanagan, ... Cell 93 (3), 445-454, 1998 | 677 | 1998 |
| Adrenocortical carcinoma T Else, AC Kim, A Sabolch, VM Raymond, A Kandathil, EM Caoili, S Jolly, ... Endocrine reviews 35 (2), 282-326, 2014 | 663 | 2014 |
| Pathophysiology of disease: an introduction to clinical medicine GD Hammer, SJ McPhee, MGH Education McGraw-Hill Education Medical, 2014 | 518 | 2014 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 501 | 2016 |
| Management of patients with adrenal cancer: recommendations of an international consensus conference DE Schteingart, GM Doherty, PG Gauger, TJ Giordano, GD Hammer, ... Endocrine-related cancer 12 (3), 667-680, 2005 | 465 | 2005 |
| Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress GD Hammer, I Krylova, Y Zhang, BD Darimont, K Simpson, NL Weigel, ... Molecular cell 3 (4), 521-526, 1999 | 428 | 1999 |
| Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results GD Hammer, JB Tyrrell, KR Lamborn, CB Applebury, ET Hannegan, ... The Journal of Clinical Endocrinology & Metabolism 89 (12), 6348-6357, 2004 | 416 | 2004 |
| Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling TJ Giordano, R Kuick, T Else, PG Gauger, M Vinco, J Bauersfeld, ... Clinical cancer research 15 (2), 668-676, 2009 | 388 | 2009 |
| Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ... The lancet oncology 16 (4), 426-435, 2015 | 279 | 2015 |
| Telomere protection by mammalian Pot1 requires interaction with Tpp1 D Hockemeyer, W Palm, T Else, JP Daniels, KK Takai, JZS Ye, ... Nature structural & molecular biology 14 (8), 754-761, 2007 | 252 | 2007 |
| Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma BS Miller, JB Ammori, PG Gauger, JT Broome, GD Hammer, GM Doherty World journal of surgery 34 (6), 1380-1385, 2010 | 230 | 2010 |
| Recent insights into organogenesis of the adrenal cortex CE Keegan, GD Hammer Trends in Endocrinology & Metabolism 13 (5), 200-208, 2002 | 220 | 2002 |
| Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma FM Barlaskar, AC Spalding, JH Heaton, R Kuick, AC Kim, DG Thomas, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 204-212, 2009 | 219 | 2009 |
| Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex AC Kim, AL Reuter, M Zubair, T Else, K Serecky, NC Bingham, GG Lavery, ... Oxford University Press for The Company of Biologists Limited 135 (15), 2593 …, 2008 | 209 | 2008 |
| Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma P Haluska, F Worden, D Olmos, D Yin, D Schteingart, GN Batzel, ... Cancer chemotherapy and pharmacology 65 (4), 765-773, 2010 | 205 | 2010 |
| Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells JL Garcia-Perez, M Morell, JO Scheys, DA Kulpa, S Morell, CC Carter, ... Nature 466 (7307), 769-773, 2010 | 175 | 2010 |
| Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin JH Heaton, MA Wood, AC Kim, LO Lima, FM Barlaskar, MQ Almeida, ... The American journal of pathology 181 (3), 1017-1033, 2012 | 159 | 2012 |
| Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma T Else, AR Williams, A Sabolch, S Jolly, BS Miller, GD Hammer The Journal of Clinical Endocrinology & Metabolism 99 (2), 455-461, 2014 | 155 | 2014 |
